Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis

N J McHugh, M Csuka, H Watson, G Belcher, A Amadi, E F Ring, C M Black, P J Maddison

Research output: Contribution to journalArticle

Abstract

Iloprost, a stable prostacyclin analogue, was given by intravenous infusion to 29 patients with severe Raynaud's phenomenon, 26 of whom had systemic sclerosis (SS), and compared with placebo infusion in a double blind crossover trial. Iloprost significantly lessened the number and the severity of attacks compared with placebo. Nine patients expressed a preference for effectiveness of treatment, eight of these in favour of Iloprost. Thermography failed to show any long term effect of Iloprost. Side effects of headache, flushing, nausea, and vomiting were common, and the inconvenience of intravenous administration may limit its routine use.
LanguageEnglish
Pages43-47
Number of pages5
JournalAnnals of the Rheumatic Diseases
Volume47
Issue number1
StatusPublished - 1988

Fingerprint

Iloprost
Raynaud Disease
Systemic Scleroderma
Epoprostenol
Placebos
Therapeutics
Intravenous Infusions
Intravenous Administration
Cross-Over Studies
Nausea
Vomiting
Headache

Keywords

  • Clinical Trials as Topic
  • Double-Blind Method
  • Epoprostenol
  • Female
  • Humans
  • Iloprost
  • Injections, Intravenous
  • Male
  • Raynaud Disease
  • Scleroderma, Systemic

Cite this

McHugh, N. J., Csuka, M., Watson, H., Belcher, G., Amadi, A., Ring, E. F., ... Maddison, P. J. (1988). Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. Annals of the Rheumatic Diseases, 47(1), 43-47.

Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. / McHugh, N J; Csuka, M; Watson, H; Belcher, G; Amadi, A; Ring, E F; Black, C M; Maddison, P J.

In: Annals of the Rheumatic Diseases, Vol. 47, No. 1, 1988, p. 43-47.

Research output: Contribution to journalArticle

McHugh, NJ, Csuka, M, Watson, H, Belcher, G, Amadi, A, Ring, EF, Black, CM & Maddison, PJ 1988, 'Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis' Annals of the Rheumatic Diseases, vol. 47, no. 1, pp. 43-47.
McHugh, N J ; Csuka, M ; Watson, H ; Belcher, G ; Amadi, A ; Ring, E F ; Black, C M ; Maddison, P J. / Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. In: Annals of the Rheumatic Diseases. 1988 ; Vol. 47, No. 1. pp. 43-47.
@article{c4dd6137e90b406fa82f3897e150a1b8,
title = "Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis",
abstract = "Iloprost, a stable prostacyclin analogue, was given by intravenous infusion to 29 patients with severe Raynaud's phenomenon, 26 of whom had systemic sclerosis (SS), and compared with placebo infusion in a double blind crossover trial. Iloprost significantly lessened the number and the severity of attacks compared with placebo. Nine patients expressed a preference for effectiveness of treatment, eight of these in favour of Iloprost. Thermography failed to show any long term effect of Iloprost. Side effects of headache, flushing, nausea, and vomiting were common, and the inconvenience of intravenous administration may limit its routine use.",
keywords = "Clinical Trials as Topic, Double-Blind Method, Epoprostenol, Female, Humans, Iloprost, Injections, Intravenous, Male, Raynaud Disease, Scleroderma, Systemic",
author = "McHugh, {N J} and M Csuka and H Watson and G Belcher and A Amadi and Ring, {E F} and Black, {C M} and Maddison, {P J}",
year = "1988",
language = "English",
volume = "47",
pages = "43--47",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis

AU - McHugh, N J

AU - Csuka, M

AU - Watson, H

AU - Belcher, G

AU - Amadi, A

AU - Ring, E F

AU - Black, C M

AU - Maddison, P J

PY - 1988

Y1 - 1988

N2 - Iloprost, a stable prostacyclin analogue, was given by intravenous infusion to 29 patients with severe Raynaud's phenomenon, 26 of whom had systemic sclerosis (SS), and compared with placebo infusion in a double blind crossover trial. Iloprost significantly lessened the number and the severity of attacks compared with placebo. Nine patients expressed a preference for effectiveness of treatment, eight of these in favour of Iloprost. Thermography failed to show any long term effect of Iloprost. Side effects of headache, flushing, nausea, and vomiting were common, and the inconvenience of intravenous administration may limit its routine use.

AB - Iloprost, a stable prostacyclin analogue, was given by intravenous infusion to 29 patients with severe Raynaud's phenomenon, 26 of whom had systemic sclerosis (SS), and compared with placebo infusion in a double blind crossover trial. Iloprost significantly lessened the number and the severity of attacks compared with placebo. Nine patients expressed a preference for effectiveness of treatment, eight of these in favour of Iloprost. Thermography failed to show any long term effect of Iloprost. Side effects of headache, flushing, nausea, and vomiting were common, and the inconvenience of intravenous administration may limit its routine use.

KW - Clinical Trials as Topic

KW - Double-Blind Method

KW - Epoprostenol

KW - Female

KW - Humans

KW - Iloprost

KW - Injections, Intravenous

KW - Male

KW - Raynaud Disease

KW - Scleroderma, Systemic

UR - http://ard.bmj.com/

M3 - Article

VL - 47

SP - 43

EP - 47

JO - Annals of the Rheumatic Diseases

T2 - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 1

ER -